Xinxing Lai

Publication Activity (10 Years)

Years Active: 2020-2023
Publications (10 Years): 4

Top Topics

Irritable Bowel Syndrome

Randomized Controlled Trial

Top Venues

Oxidative medicine and cellular longevity

Clinical and experimental hypertension (New York, N.Y. : 1993)

Circulation. Cardiovascular quality and outcomes

This page only lists publications with an associated author ORCID identifier.

Publications

Xinxing Lai, Zhenghao Fang, Zhenyu Dong, Shengxian Wu, Xiao-Hua Zhou, Ying Gao
A propensity score matched comparison of blood pressure lowering in essential hypertension patients treated with antihypertensive Chinese herbal Medicine: comparing the real-world registry data vs. randomized controlled trial. Clinical and experimental hypertension (New York, N.Y. : 1993) 45 (1) (2023)
Xinxing Lai, Zhenyu Dong, Shengxian Wu, Xiaohua Zhou, Genming Zhang, Shangquan Xiong, Wei Wu, Rui Cao, Xiaolong Wang, Qi Hua, Jinhang Du, Jinying Fan, Jingyuan Mao, Weimin Jiang, Huishu Yuan, Yushan Chen, Yong Xu, Zhanquan Li, Jun Zhang, Guiying Dong, Hui Zhen, Ru Ding, Zonggui Wu, Ying Gao
Efficacy and Safety of Chinese Herbal Medicine Compared With Losartan for Mild Essential Hypertension: A Randomized, Multicenter, Double-Blind, Noninferiority Trial. Circulation. Cardiovascular quality and outcomes 15 (3) (2022)
Xin Wang, Min Wu, Xinxing Lai, Jiahui Zheng, Minghua Hu, Yan Li, Shao Li
Network Pharmacology to Uncover the Biological Basis of Spleen Qi Deficiency Syndrome and Herbal Treatment. Oxidative medicine and cellular longevity 2020 (2020)
Xinxing Lai, Jian Liu, Tianyi Zhang, Lu-Da Feng, Ping Jiang, Ligaoge Kang, Qiang Liu, Ying Gao
Clinical, laboratory and imaging predictors for critical illness and mortality in patients with COVID-19: protocol for a systematic review and meta-analysis. BMJ open 10 (12) (2020)